High Stake Search for the Next Lipitor

Published November 26, 2012

High Stake Search For The Next Lipitor

Filed under: drug treatment news 2011

Pfizer (PFE) has recently released data on its PCSK9 inhibitor, RN 316, showing the drug at its highest dose lowered bad cholesterol in patients on statins by 80 percent after their first treatment. Cholesterol fell so low for some in the 135-person …
Read more on Seeking Alpha

Hope for effective new malaria treatment

Filed under: drug treatment news 2011

In addition, 102 cases were reported in Europe by the World Health Organization (WHO) in 2011. Although treatments for malaria are currently available, the Plasmodium parasite is rapidly becoming resistant to the most common drugs, and new strategies …
Read more on Phys.Org

Expiring Patents Could Mean Huge Profits for This Little-Known Stock

Filed under: drug treatment news 2011

Among the latest are generic versions of Pfizer's $ 5.3-billion high-cholesterol medication Lipitor and Johnson & Johnson's $ 1.4-billion attentiondeficit and hyperactivity disorder (ADHD) treatment Concerta. Watson … Based on a December 2011 …
Read more on NASDAQ